DENTSPLY SIRONA (NASDAQ:XRAY) Hits New 52-Week Low - Should You Sell?

Key Points

• DENTSPLY SIRONA shares hit a new 52-week low of $11.96, down from a previous close of $12.22, with a trading volume of 595,225 shares.
• Equity analysts have reduced their price targets for DENTSPLY SIRONA, with estimates now ranging from $13.00 to $24.00, maintaining a consensus rating of "Hold" with an average target of $18.00.
• The company recently announced a quarterly dividend of $0.16 per share, yielding 5.3%, with a dividend payout ratio of -13.50%.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report) hit a new 52-week low on Friday . The company traded as low as $11.97 and last traded at $11.96, with a volume of 595225 shares. The stock had previously closed at $12.22.

Analysts Set New Price Targets

Several equities analysts recently commented on the company. UBS Group dropped their price objective on DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating on the stock in a research note on Friday, August 8th. Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a research report on Friday, September 26th. Barrington Research decreased their price target on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set an "outperform" rating on the stock in a report on Friday, August 8th. Wall Street Zen raised shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Friday, September 26th. Finally, Evercore ISI decreased their price target on shares of DENTSPLY SIRONA from $17.00 to $13.00 and set an "in-line" rating on the stock in a report on Wednesday. Two analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $18.00.

DENTSPLY SIRONA Trading Down 1.6%

The firm has a market cap of $2.40 billion, a P/E ratio of -2.55, a PEG ratio of 0.77 and a beta of 0.96. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11. The stock has a 50 day moving average of $13.55 and a 200 day moving average of $14.63.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The firm had revenue of $936.00 million for the quarter, compared to analysts' expectations of $929.67 million. During the same period last year, the firm earned $0.49 earnings per share. The company's revenue for the quarter was down 4.9% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. As a group, equities research analysts predict that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 10th. Stockholders of record on Friday, September 26th will be paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 5.3%. The ex-dividend date of this dividend is Friday, September 26th. DENTSPLY SIRONA's dividend payout ratio (DPR) is -13.50%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. GAMMA Investing LLC boosted its holdings in shares of DENTSPLY SIRONA by 1,462.9% during the first quarter. GAMMA Investing LLC now owns 99,351 shares of the medical instruments supplier's stock worth $1,484,000 after purchasing an additional 92,994 shares during the period. Pallas Capital Advisors LLC boosted its holdings in shares of DENTSPLY SIRONA by 222.5% during the first quarter. Pallas Capital Advisors LLC now owns 44,865 shares of the medical instruments supplier's stock worth $670,000 after purchasing an additional 30,953 shares during the period. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of DENTSPLY SIRONA by 39.0% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 53,903 shares of the medical instruments supplier's stock worth $805,000 after purchasing an additional 15,117 shares during the period. Sound Income Strategies LLC boosted its holdings in shares of DENTSPLY SIRONA by 43.7% during the first quarter. Sound Income Strategies LLC now owns 347,841 shares of the medical instruments supplier's stock worth $5,197,000 after purchasing an additional 105,777 shares during the period. Finally, Hanson & Doremus Investment Management purchased a new stake in shares of DENTSPLY SIRONA during the first quarter worth about $90,000. 95.70% of the stock is owned by institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.